von Tobias Borgers | Aug. 19, 2019 | Novartis
Media Release Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off. Read More Video – The future of Novartis Our future is as a leading focused medicines company, powered by data science and advanced therapy...
von Tobias Borgers | Aug. 19, 2019 | Boehringer
The Global Anticoagulants market report offers historical and forecast market data, demand, application details, price trends, and company shares of the leading Anticoagulants by geography. The report splits the market size, by volume and value, on the basis of...
von Tobias Borgers | Aug. 18, 2019 | Glaxo
Issued: London UK – LSE Announcement TESARO, an oncology-focused business acquired by GlaxoSmithKline plc (LSE/NYSE: GSK), announced today the presentation of data from the Phase 1/2 GARNET study evaluating dostarlimab in women with recurrent or advanced endometrial...
von Tobias Borgers | Aug. 18, 2019 | Boehringer
The Global Anticoagulants market report analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of...
von Tobias Borgers | Aug. 18, 2019 | GEA
GEA stellte dabei auch seine eigenen, laufenden Aktivitäten in Sachen „Open Innovation“ vor, beispielsweise die Kooperation mit den Accelerator-Programmen „garage33“ und „it’s OWL“, die neue Entwicklungen sowie Gründertum fördern und beschleunigen. Die „garage33“...
